Identifies clinical impact of carbapenem-resistant Enterobacteriaceae in children, suggesting urgent need for effective treatment strategies.
Introduction Carbapenem-resistant Enterobacteriaceae (CRE) is the most common clinical pathogens. Investigating the antimicrobial resistance, hypervirulence and clinical characteristics of CRE isolated from children is helpful to guide for anti-infection treatments. Methods Nonduplicated CRE clinical strains were isolated and mass spectrometry was applied to identify clinical isolated strains. VITEK 2 Compact system and Kirby-Bauer method were used to analyze the antimicrobial susceptibility. Besides, the drug resistance and hypervirulence associated genes were detected by polymerase chain reaction (PCR) and sequencing. Results A total of 281 non-duplicated CRE strains were identified in this study. Klebsiella pneumoniae (55.87%), Escherichia coli (36.65%) and Klebsiella aerogenes (3.20%) were the top 3 CRE strains. These strains showed high resistance to most of antimicrobial agents and carried carbapenemase genes, including bla OXA-232 (38.08%), bla KPC-2 (20.28%), bla OXA-1 (17.08%), bla NDM-5 (10.32%) and bla NDM-1 (8.90%). In addition, bla TEM-1 (98.93%), bla CTX-M-14 (88.61%) and bla SHV-11 (87.54%) were the prevalent extended-spectrum β-lactamase (ESBL) genes in these strains, while the detection rate of AmpC cephalosporinase genes were not high. Besides, 45 (28.66%) carbapenem-resistant Klebsiella pneumoniae (CRKP) strains carried hypervirulence associated genes iucA (24.84%), p rmpA (17.83%), peg-344 (17.20%), and p rmpA2 (9.55%). Among them, 22 (14.01%) CRKP strains were also identified as carbapenem-resistant and hypervirulent Klebsiella pneumoniae (CR-HVKP). What’s worse, the patients infected with CR-HVKP had a worse prognosis overall. Conclusion This study revealed the drug resistance, hypervirulence and epidemiology of CRE strains in pediatric patients in Suzhou of eastern China. Unfortunately, CR-HVKP strains with more several infection were also identified, which should be of great concern to clinicians.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: